Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.944 on 12-06-2026 at 08:33:54
Change $0.00 0%
Buy $0.95
Sell $0.942
Last Trade: Unknown 7,112.00 at $0.942953
Day's Volume: 141,582
Last Close: $0.944
Open: $0.944
ISIN: GB00BDGKMY29
Day's Range $0.94 - $0.944
52wk Range: $0.858 - $1.00
Market Capitalisation: $1.06b
VWAP: $0.943536
Shares in Issue: 1.12b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 7,112 $0.942953 Ordinary
Currency Conversion
09:33:53 - 12-Jun-26
Sell* 35 $0.944 SI Trade
09:05:59 - 12-Jun-26
Sell* 4 $0.944 SI Trade
09:05:59 - 12-Jun-26
Buy* 8,868 $0.944 Automatic Execution
09:05:59 - 12-Jun-26
Sell* 9,816 $0.942 Automatic Execution
09:05:59 - 12-Jun-26
Unknown* 440 $0.947633 Ordinary
Currency Conversion
08:38:33 - 12-Jun-26
Buy* 4 $0.948 SI Trade
08:32:09 - 12-Jun-26
Buy* 21 $0.946 SI Trade
08:30:01 - 12-Jun-26
Buy* 3 $0.948 SI Trade
08:25:05 - 12-Jun-26
Sell* 100 $0.94 SI Trade
08:22:01 - 12-Jun-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Jun 2026 (Thu) 0.946 0.95 0.944 0.944 924,800
10th Jun 2026 (Wed) 0.956 0.96 0.948 0.95 1,590,900
9th Jun 2026 (Tue) 0.96 0.96 0.956 0.956 1,247,357
8th Jun 2026 (Mon) 0.96 0.962 0.958 0.96 872,512
5th Jun 2026 (Fri) 0.958 0.962 0.958 0.96 690,442
4th Jun 2026 (Thu) 0.962 0.966 0.956 0.956 2,510,950
3rd Jun 2026 (Wed) 0.962 0.966 0.958 0.966 1,224,385
2nd Jun 2026 (Tue) 0.966 0.966 0.958 0.96 641,970
1st Jun 2026 (Mon) 0.966 0.966 0.96 0.96 805,909
29th May 2026 (Fri) 0.966 0.966 0.958 0.958 1,066,342
28th May 2026 (Thu) 0.972 0.972 0.964 0.966 1,492,517
27th May 2026 (Wed) 0.964 1.00 0.95 0.97 1,958,046
26th May 2026 (Tue) 0.96 0.966 0.948 0.96 1,231,665
25th May 2026 (Mon) 0.95 0.95 0.95 0.95 0
22nd May 2026 (Fri) 0.96 0.96 0.95 0.95 2,236,157
21st May 2026 (Thu) 0.956 0.96 0.948 0.958 2,474,593
20th May 2026 (Wed) 0.95 0.958 0.948 0.956 3,340,108
19th May 2026 (Tue) 0.95 0.954 0.946 0.952 1,179,283
18th May 2026 (Mon) 0.936 0.952 0.936 0.946 1,365,479
15th May 2026 (Fri) 0.94 0.944 0.94 0.942 981,506
14th May 2026 (Thu) 0.944 0.944 0.94 0.942 728,113
13th May 2026 (Wed) 0.936 0.942 0.936 0.942 1,000,471
12th May 2026 (Tue) 0.94 0.942 0.938 0.938 1,182,219
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
9th Jun 2026 8:00 am RNS NEW INVESTMENT
3rd Jun 2026 11:40 am RNS New Investment
1st Jun 2026 4:51 pm RNS Director/PDMR Shareholding
1st Jun 2026 1:39 pm RNS Total Voting Rights
26th May 2026 6:15 pm RNS Transaction in Own Shares
22nd May 2026 6:15 pm RNS Transaction in Own Shares
22nd May 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st May 2026 6:15 pm RNS Transaction in Own Shares
20th May 2026 6:15 pm RNS Transaction in Own Shares
15th May 2026 6:15 pm RNS Transaction in Own Shares
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

UK shareholder meetings calendar - next 7 days

10th Jun 2026 13:22

Read More

BioPharma Credit commits up to CHF75 million to Idorsia loan

9th Jun 2026 11:08

(Alliance News) - BioPharma Credit PLC on Tuesday announced a new investment of up to CHF75 million, around USD94.2 million, in Allschwil, Switzerland-based Idorsia Pharmaceuticals Ltd as part of a larger CHF250 million senior secured financing package. Read More

TRADING UPDATES: Afentra and Portmeirion intend to launch fundraises

3rd Jun 2026 21:43

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

UK dividends calendar - next 7 days

22nd May 2026 14:22

Read More

IN BRIEF: BioPharma Credit notes full prepayment of loan facility

6th May 2026 11:59

BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Regarding Alphatec Holdings Inc, BioPharma Credit notes the prepayment in full of its USD200 million senior secured loan facility, of which it had an investment of USD35 million. BioPharma Credit says it earned a 14.91% gross internal rate of return and an 11.93% net internal rate of return on its Alphatec Holdings investment. Alphatec on Tuesday announced it entered into a new credit facility, including a USD125 million revolving credit facility and a USD175 million term loan A. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,447.39
Change143.51

Login to your account

Forgot Password?

Not Registered